Maturitas
Maturitas is a peer-reviewed medical journal covering research on all aspects of menopause. The journal was established in 1978 and is published by Elsevier. The editor-in-chief is Margaret Rees (University of Oxford). The journal is abstracted and indexed in PubMed/MEDLINE, Scopus, and the Science Citation Index Expanded. According to the Journal Citation Reports, the journal has a 2019 impact factor of 3.654.
History[edit | edit source]
Maturitas was established in 1978. It is a peer-reviewed medical journal that focuses on the study of menopause. The journal is published by Elsevier, a renowned publishing company known for its vast collection of scientific, technical, and medical literature.
Scope[edit | edit source]
The scope of Maturitas includes all aspects of menopause. This includes, but is not limited to, clinical and epidemiological research, basic science research, and health and social issues related to menopause.
Editor-in-Chief[edit | edit source]
The current editor-in-chief of Maturitas is Margaret Rees, a professor at the University of Oxford. Rees is known for her extensive research and contributions to the field of menopause.
Abstracting and Indexing[edit | edit source]
Maturitas is abstracted and indexed in several databases. These include PubMed/MEDLINE, Scopus, and the Science Citation Index Expanded. These databases are widely used in the scientific community for research and reference purposes.
Impact Factor[edit | edit source]
According to the Journal Citation Reports, Maturitas has a 2019 impact factor of 3.654. The impact factor is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal within its field.
| Maturitas Resources | ||
|---|---|---|
|
| |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
